Gossamer Bio board approves amended bylaws effective Sept. 3
Gossamer Bio said its board approved amended bylaws effective Sept. 3, 2026. The company plans to present on seralutinib at the Cantor Global Healthcare Conference in New York on Sept. 9, 2026, with follow-up meetings planned.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.